The Latest Cardiac and Vascular News
Alliance to Focus on Improving the Quality, Access, and Value of Cardiovascular Disease Care in Northeast Florida NEW YORK, July 20, 2021 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care delivery platform, today announced a partnership with First Coast Heart & Vascular Center, P.C., the largest independent cardiovascular disease physician group in Northeast […]
Beverly Huss to join Board of Directors SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced it has closed an $80 million equity financing. Sands Capital, Sio Capital and an undisclosed strategic investor joined all existing investors in this financing. The […]
MARLTON, N.J., July 19, 2021 (GLOBE NEWSWIRE) — Impulse Dynamics (USA) Inc., a company dedicated to improving the lives of people with heart failure (HF), today announced the appointment of Jason Spees to the position of President, Chief Commercial Officer. Spees, who will be based in the company’s headquarters office […]
BOSTON, July 19, 2021 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the appointment of Allison Dorval, chief financial officer of Voyager Therapeutics, Inc. (“Voyager”), as a member […]
GETINGE, Sweden, July 16, 2021 /PRNewswire/ — “In total, sales increased by 3.6% organically compared with the second quarter 2020, and the order intake declined by 6.1% organically compared with 2020 when we received very large orders of advanced ICU ventilators”, says Mattias Perjos, President & CEO. “Cash flow remained strong and net debt […]
Amy Burroughs and Dr. Charles Semba Bring Extensive and Complementary Experience in Building Specialty Therapeutics Companies MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the election of two industry veterans to the Company’s Board of […]
ENGLEWOOD, Colo., July 15, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q2 2021. Thomas Sandgaard, CEO of Zynex said: “Our […]
CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $14.00 per share. All of the shares of common stock are being offered […]
Transforming the way heart disease is diagnosed and treated, HeartFlow’s artificial intelligence-enabled software platform brings precision heart care to cardiology. The HeartFlow Analysis is the first and only non-invasive tool to assist with the diagnosis, management and treatment of patients with heart disease, the most common type of cardiovascular disease […]
Vector Provides the Expert, Timely Cardiac Insights that Clinics Need to Deliver the Highest Level of Care NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–MedAxiom, the nation’s leading cardiovascular healthcare membership organization and performance community, is excited to announce its industry partnership with Vector Remote Care, a complete cardiac remote monitoring solution that makes it simple […]
